Skip to main content

Atrion Corporation Value Stock - Dividend - Research Selection

Atrion Corporation

ISIN: US0499041053, WKN: 922778

Market price date: 27.05.2021
Market price: 614,05 USD




Atrion Corporation Fundamental data and company key figures of the share

Annual reports in USD
Key figures 05-03-2021
Cash flow
Net operating cash flow 38.970.000
Capital Expenditures -21.886.000
Free cash flow 17.084.000
Balance sheet
Total Equity 240.442.000
Liabilities & Shareholders equity 266.890.000
Income statement
Net income 32.115.000
Eps (diluted) 17,440
Diluted shares outstanding 1.850.000
Net sales/revenue 147.591.000

Fundamental ratios calculated on: 27-05-2021

Ratios
Key figures 27-05-2021
Cash flow
P/C 29,06
   
P/FC 66,50
Balance sheet
ROI12,03
ROE90,09
Income statement
P/E35,21
Div. Yield1,08%
P/B4,71
P/S7,70


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolATRI
Market Capitalization1.132.496.000,00 USD
Country
IndicesNASDAQ Comp.
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split1996-12-03,3.0000/2.0000; 1983-06-06,2.0000/1.0000; 1980-04-28,100.0000/120.0000
Internetwww.atrioncorp.com


Description of the company

Atrion Corporation (Atrion), and its subsidiaries, develop and manufacture products, primarily for medical applications. The Company´s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. During the year ended December 31, 2011, the Company´s fluid delivery products accounted for 38% of the Company´s revenues. These products include valves that promote infection control and needle safety. The Company has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. The Company also makes tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications, including anesthesia and oncology.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.atrioncorp.com